Role of autophagy in head and neck cancer and therapeutic resistance

Oral Diseases

Volumn 21, Issue 3, 2015, Pages 283-291

  Sannigrahi, M K ^a   Singh, V ^a   Sharma, R ^a   Panda, N K ^a   Khullar, M ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Autophagy; Chemoresistance; Head and neck squamous cell carcinomas; Human papillomaviruses; Hypoxia induced factor 1 ; Mammalian target of rapamycin (C1 and C2); P53; Phosphoinositide 3 kinase; Radioresistance

Indexed keywords

ALCOHOL; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN P53;

APOPTOSIS; AUTOPHAGY; CANCER RESISTANCE; CARCINOGENESIS; CELL DEATH; CELL METABOLISM; CELL SURVIVAL; DRUG TARGETING; EPITHELIUM CELL; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOXIA; METABOLIC STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; SMOKING; TOBACCO; WART VIRUS; CARCINOMA, SQUAMOUS CELL; DRINKING BEHAVIOR; DRUG RESISTANCE; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; PAPILLOMAVIRUS INFECTION; RADIATION TOLERANCE;

ALCOHOL DRINKING; AUTOPHAGY; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PAPILLOMAVIRUS INFECTIONS; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84925044445     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12254     Document Type: Review

References (91)

1. Alexander A, Cai SL, Kim J et al (2010). ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci USA 107: 4153-4158.
2. Apel A, Zentgraf H, Buchler MW, Herr I (2009). Autophagy-A double-edged sword in oncology. Int J Cancer 125: 991-995.
3. Bauvy C, Gane P, Arico S, Codogno P, Ogier-Denis E (2001). Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp Cell Res 268: 139-149.
4. Bensaad K, Tsuruta A, Selak MA et al (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120.
5. Bodily JM, Mehta KP, Laimins LA (2011). Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res 71: 1187-1195.
6. Brugarolas J, Lei K, Hurley RL et al (2004). Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18: 2893-2904.
7. Budanov AV, Karin M (2008). p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451-460.
8. Bursch W, Ellinger A, Kienzl H et al (1996). Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17: 1595-1607.
9. Carracedo A, Pandolfi PP (2008). The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27: 5527-5541.
10. Chang CC, Lin BR, Chen ST, Hsieh TH, Li YJ, Kuo MY (2011). HDAC2 promotes cell migration/invasion abilities through HIF-1alpha stabilization in human oral squamous cell carcinoma. J Oral Pathol Med 40: 567-575.
11. Chang HW, Lee YS, Nam HY et al (2013). Knockdown of beta-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines. Cell Signal 25: 839-847.
12. Chen ZH, Kim HP, Sciurba FC et al (2008). Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 3: e3316.
13. Chen ZH, Lam HC, Jin Y et al (2010). Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci USA 107: 18880-18885.
14. Chen SF, Yu FS, Chang YC, Fu E, Nieh S, Lin YS (2012). Role of human papillomavirus infection in carcinogenesis of oral squamous cell carcinoma with evidences of prognostic association. J Oral Pathol Med 41: 9-15.
15. Claerhout S, Verschooten L, Van Kelst S et al (2010). Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma. Int J Cancer 127: 2790-2803.
16. Condon LT, Ashman JN, Ell SR, Stafford ND, Greenman J, Cawkwell L (2002). Overexpression of Bcl-2 in squamous cell carcinoma of the larynx: a marker of radioresistance. Int J Cancer 100: 472-475.
17. Cosse JP, Rommelaere G, Ninane N, Arnould T, Michiels C (2010). BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathway. Biochem Pharmacol 80: 1160-1169.
18. Craig AL, Holcakova J, Finlan LE et al (2010). DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation. Mol cancer 9: 195.
19. Dancey J (2010). mTOR signaling and drug development in cancer. Nat Rev Clin Oncol 7: 209-219.
20. Griffin LM, Cicchini L, Pyeon D (2013). Human papillomavirus infection is inhibited by host autophagy in primary human keratinocytes. Virology 437: 12-19.
21. Gupta V, Bamezai RN (2010). Human pyruvate kinase M2: a multifunctional protein. Protein Sci 19: 2031-2044.
22. Hamid A, Kaur J (2007). Long-term alcohol ingestion alters the folate-binding kinetics in intestinal brush border membrane in experimental alcoholism. Alcohol 41: 441-446.
23. Harrigan JA, Vezina CM, McGarrigle BP et al (2004). DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene. Toxicol Sci 77: 307-314.
24. Huang Y, Chuang AY, Romano RA et al (2010). Phospho-DeltaNp63alpha/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure. Cell Cycle 9: 328-338.
25. Huang Y, Guerrero-Preston R, Ratovitski EA (2012). Phospho-DeltaNp63alpha-dependent regulation of autophagic signaling through transcription and micro-RNA modulation. Cell Cycle 11: 1247-1259.
26. Huang L, Wang S, Li SS, Yang XM (2013). Prognostic significance of Beclin-1 expression in laryngeal squamous cell carcinoma. Pathol Oncol Res 19: 771-777.
27. Hwang JW, Chung S, Sundar IK et al (2010). Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD. Arch Biochem Biophys 500: 203-209.
28. Jerhammar F, Ceder R, Garvin S, Grenman R, Grafstrom RC, Roberg K (2010). Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biol Ther 10: 1244-1251.
29. Jia L, Dourmashkin RR, Allen PD, Gray AB, Newland AC, Kelsey SM (1997). Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol 98: 673-685.
30. Kalyankrishna S, Grandis JR (2006). Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 24: 2666-2672.
31. Kim HP, Wang X, Chen ZH et al (2008). Autophagic proteins regulate cigarette smoke-induced apoptosis: protective role of heme oxygenase-1. Autophagy 4: 887-895.
32. Kuwahara Y, Oikawa T, Ochiai Y et al (2011). Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy. Cell Death Dis 2: e177.
33. Lambert LA, Qiao N, Hunt KK et al (2008). Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res 68: 7966-7974.
34. Langendijk JA, Psyrri A (2010). The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies. Ann Oncol 21: 1931-1934.
35. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011). The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.
36. Liang XH, Jackson S, Seaman M et al (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
37. Lin MH, Hsieh WF, Chiang WF et al (2010a). Autophagy induction by the 30-100 kDa fraction of areca nut in both normal and malignant cells through reactive oxygen species. Oral Oncol 46: 822-828.
38. Lin TY, Chang JT, Wang HM et al (2010b). Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy. Int J Radiat Oncol Biol Phys 78: 246-256.
39. Liu D, Yang Y, Liu Q, Wang J (2011). Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol 28: 105-111.
40. Livesey KM, Tang D, Zeh HJ, Lotze MT (2009). Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs 10: 1269-1279.
41. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya KA (2003). Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol 39: 106-114.
42. Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R (2011). Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cells. PLoS ONE 6: e14728.
43. Maddocks OD, Vousden KH (2011). Metabolic regulation by p53. J Mol Med (Berl) 89: 237-245.
44. Martin AP, Mitchell C, Rahmani M, Nephew KP, Grant S, Dent P (2009). Inhibition of MCL-1 enhances lapatinib toxicity and overcomes lapatinib resistance via BAK-dependent autophagy. Cancer Biol Ther 8: 2084-2096.
45. McLaughlin-Drubin ME, Munger K (2009). The human papillomavirus E7 oncoprotein. Virology 384: 335-344.
46. Mishra NC, Rir-Sima-Ah J, Langley RJ et al (2008). Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J Immunol 180: 7655-7663.
47. Moergel M, Abt E, Stockinger M, Kunkel M (2010). Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma. Oral Oncol 46: 667-671.
48. Murrow L, Debnath J (2013). Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu Rev Pathol 8: 105-137.
49. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011). Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572.
50. Nam HY, Han MW, Chang HW et al (2013). Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Res 73: 4267-4277.
51. Nathan CO, Amirghahari N, Rong X et al (2007). Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer. Cancer Res 67: 2160-2168.
52. Neville BW, Day TA (2002). Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215.
53. Nomura H, Uzawa K, Yamano Y et al (2009). Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis. Hum Pathol 40: 83-91.
54. O'Donovan TR, O'Sullivan GC, McKenna SL (2011). Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. Autophagy 7: 509-524.
55. Pae HO, Lee YC, Chung HT (2008). Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat Inflammation Allergy Drug Discovery 2: 159-165.
56. Paglin S, Hollister T, Delohery T et al (2001). A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61: 439-444.
57. Pattingre S, Tassa A, Qu X et al (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927-939.
58. Philip B, Ito K, Moreno-Sanchez R, Ralph SJ (2013). HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression. Carcinogenesis 34: 1699-1707.
59. Poeta ML, Manola J, Goldwasser MA et al (2007). TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med 357: 2552-2561.
60. Qu X, Yu J, Bhagat G et al (2003). Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Investig 112: 1809-1820.
61. Ramakrishnan S, Nguyen TM, Subramanian IV, Kelekar A (2007). Autophagy and angiogenesis inhibition. Autophagy 3: 512-515.
62. Ratovitski EA (2011). DeltaNp63alpha/IRF6 interplay activates NOS2 transcription and induces autophagy upon tobacco exposure. Arch Biochem Biophys 506: 208-215.
63. Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, du Manoir S (2001). A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 61: 4122-4129.
64. Rodriguez T, Altieri A, Chatenoud L et al (2004). Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 40: 207-213.
65. Rouschop KM, van den Beucken T, Dubois L et al (2010). The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Investig 120: 127-141.
66. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T (1998). Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153: 1741-1748.
67. Schuller HM (2007). Nitrosamines as nicotinic receptor ligands. Life Sci 80: 2274-2280.
68. Shintani T, Klionsky DJ (2004). Autophagy in health and disease: a double-edged sword. Science 306: 990-995.
69. Smeets SJ, Braakhuis BJ, Abbas S et al (2006). Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 25: 2558-2564.
70. Spangle JM, Munger K (2010). The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 84: 9398-9407.
71. Stampfli MR, Anderson GP (2009). How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9: 377-384.
72. Sui X, Chen R, Wang Z et al (2013). Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 4: e838.
73. Sun Y, Zhang J, Peng ZL (2009). Beclin1 induces autophagy and its potential contributions to sensitizes SiHa cells to carboplatin therapy. Int J Gynecol Cancer 19: 772-776.
74. Surviladze Z, Sterk RT, DeHaro SA, Ozbun MA (2013). Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol 87: 2508-2517.
75. Talis AL, Huibregtse JM, Howley PM (1998). The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 273: 6439-6445.
76. Toussaint-Smith E, Donner DB, Roman A (2004). Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 23: 2988-2995.
77. Tu HF, Chang KW, Chiang WF et al (2011). The frequent co-expression of the oncogenes PIK3CA and PAK1 in oral carcinomas. Oral Oncol 47: 211-216.
78. Uzawa K, Ishigami T, Fushimi K et al (2011). Targeting fibroblast growth factor receptor 3 enhances radiosensitivity in human squamous cancer cells. Oncogene 30: 4447-4452.
79. Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA (2009). Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS ONE 4: e6251.
80. Vigneswaran N, Wu J, Song A, Annapragada A, Zacharias W (2011). Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC). Exp Mol Pathol 90: 215-225.
81. Voss V, Senft C, Lang V et al (2010). The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res 8: 1002-1016.
82. Was H, Dulak J, Jozkowicz A (2010). Heme oxygenase-1 in tumor biology and therapy. Curr Drug Targets 11: 1551-1570.
83. Wei Y, Kadia T, Tong W et al (2010). The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy. Autophagy 6: 976-978.
84. Wu WK, Sakamoto KM, Milani M et al (2010a). Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy. Drug Resist Updat 13: 87-92.
85. Wu Z, Chang PC, Yang JC et al (2010b). Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors. Genes Cancer 1: 40-49.
86. Yang YL, Ji C, Bi ZG et al (2013). Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells. PLoS ONE 8: e54736.
87. Zang Y, Thomas SM, Chan ET et al (2012). The next generation proteasome inhibitors carfilzomib and oprozomib activate prosurvival autophagy via induction of the unfolded protein response and ATF4. Autophagy 8: 1873-1874.
88. Zhang J, Ney PA (2009). Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 16: 939-946.
89. Zhao M, Mydlarz WK, Zhou S, Califano J (2008). Head and neck cancer cell lines are resistant to mitochondrial-depolarization-induced apoptosis. ORL J Otorhinolaryngol Relat Spec 70: 257-263.
90. Zhou X, Munger K (2009). Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation. Virology 385: 192-197.
91. Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P (1999). Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA 96: 1291-1296.